NO933101L - Farmasoeytiske sammensetninger og anvendelser av vannopploeselige celluloseetere med hoey viskositetsgrad - Google Patents

Farmasoeytiske sammensetninger og anvendelser av vannopploeselige celluloseetere med hoey viskositetsgrad

Info

Publication number
NO933101L
NO933101L NO93933101A NO933101A NO933101L NO 933101 L NO933101 L NO 933101L NO 93933101 A NO93933101 A NO 93933101A NO 933101 A NO933101 A NO 933101A NO 933101 L NO933101 L NO 933101L
Authority
NO
Norway
Prior art keywords
levels
compositions
eaters
applications
pharmaceutical compositions
Prior art date
Application number
NO93933101A
Other languages
English (en)
Other versions
NO933101D0 (no
NO304968B1 (no
Inventor
Jennifer B Dressman
Christos Reppas
Stephen W Tobey
Cynthia W Sowle
Original Assignee
Univ Michigan
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27098725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO933101(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan, Dow Chemical Co filed Critical Univ Michigan
Publication of NO933101D0 publication Critical patent/NO933101D0/no
Publication of NO933101L publication Critical patent/NO933101L/no
Publication of NO304968B1 publication Critical patent/NO304968B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/188—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO933101A 1991-03-01 1993-08-31 Spiselig sammensetning for reduksjon av serumlipidnivÕer eller reduksjon av °kning i blodglukosenivÕ etter mÕltid, samt dens fremstilling NO304968B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66338191A 1991-03-19 1991-03-19
US87060192A 1992-02-21 1992-02-21
PCT/US1992/001515 WO1992015312A1 (en) 1991-03-01 1992-02-28 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers

Publications (3)

Publication Number Publication Date
NO933101D0 NO933101D0 (no) 1993-08-31
NO933101L true NO933101L (no) 1993-10-19
NO304968B1 NO304968B1 (no) 1999-03-15

Family

ID=27098725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933101A NO304968B1 (no) 1991-03-01 1993-08-31 Spiselig sammensetning for reduksjon av serumlipidnivÕer eller reduksjon av °kning i blodglukosenivÕ etter mÕltid, samt dens fremstilling

Country Status (16)

Country Link
EP (1) EP0502666B2 (no)
JP (1) JP3436537B2 (no)
KR (1) KR100227002B1 (no)
AT (1) ATE206927T1 (no)
AU (2) AU669654B2 (no)
CA (1) CA2062091C (no)
DE (1) DE69232126T3 (no)
ES (1) ES2168256T3 (no)
FI (1) FI933809A (no)
HU (1) HU222487B1 (no)
IE (1) IE920660A1 (no)
IL (1) IL101113A (no)
MX (1) MX9200888A (no)
NO (1) NO304968B1 (no)
NZ (1) NZ241778A (no)
WO (1) WO1992015312A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US6432442B1 (en) 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
US6899892B2 (en) 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
EP2079476B1 (en) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Uses of hydroxypropyl methylcellulose for preventing or treating metabolic syndrome
ITFI20120268A1 (it) 2012-12-03 2014-06-04 Diopeite Consulting Ltd Composizioni farmaceutiche per il trattamento dell'obesita'
WO2015066035A1 (en) * 2013-10-28 2015-05-07 The Forsyth Institute Compositions and methods for evaluating metabolic syndrome and related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802741A (en) * 1953-09-21 1957-08-13 Dow Chemical Co Cake mixes containing water-soluble cellulose ethers
US3709876A (en) * 1972-04-10 1973-01-09 Dow Chemical Co Water soluble hydroxyethyl methyl cellulose ether thickener for latex paint
US4284649A (en) * 1977-11-22 1981-08-18 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4451490A (en) * 1982-03-08 1984-05-29 General Foods Corporation High quality, reduced-calorie cake containing cellulose and process thereof
NZ207125A (en) * 1983-02-17 1986-07-11 Merrell Pharma Inc Bulk laxative composition containing water-soluble cellulose ether
FI895708A0 (fi) * 1989-02-10 1989-11-29 Alko Ab Oy Vattenloeslig soenderdelningsprodukt.

Also Published As

Publication number Publication date
JP3436537B2 (ja) 2003-08-11
ATE206927T1 (de) 2001-11-15
HU222487B1 (hu) 2003-07-28
DE69232126D1 (de) 2001-11-22
FI933809A (fi) 1993-10-01
MX9200888A (es) 1994-07-29
IL101113A (en) 1999-11-30
EP0502666A1 (en) 1992-09-09
DE69232126T2 (de) 2002-06-27
EP0502666B2 (en) 2007-11-21
ES2168256T3 (es) 2002-06-16
JPH06507393A (ja) 1994-08-25
AU669654B2 (en) 1996-06-20
CA2062091C (en) 2002-12-17
KR100227002B1 (ko) 1999-10-15
AU1127492A (en) 1992-08-27
AU5200096A (en) 1996-07-18
DE69232126T3 (de) 2008-07-17
CA2062091A1 (en) 1992-09-02
FI933809A0 (fi) 1993-08-31
IL101113A0 (en) 1992-11-15
WO1992015312A1 (en) 1992-09-17
IE920660A1 (en) 1992-09-09
NZ241778A (en) 1995-04-27
NO933101D0 (no) 1993-08-31
HUT67327A (en) 1995-03-28
AU689035B2 (en) 1998-03-19
EP0502666B1 (en) 2001-10-17
NO304968B1 (no) 1999-03-15

Similar Documents

Publication Publication Date Title
Fu et al. Bioavailability of tocotrienols: evidence in human studies
Proesmans et al. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
BRPI0007820B8 (pt) formulações farmacêuticas agonistas de exendina e seus usos
BG105531A (en) Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
CN104619329B (zh) 用于治疗与升高的诱导型一氧化氮合酶相关联的疾病的半乳糖‑鼠李糖半乳糖醛酸酯组合物
NO933101L (no) Farmasoeytiske sammensetninger og anvendelser av vannopploeselige celluloseetere med hoey viskositetsgrad
BRPI0309421A8 (pt) Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
US20100215689A1 (en) Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
KR820002223B1 (ko) 갈락토만난의 제제방법
OA07536A (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
RU2108788C1 (ru) Лекарственное средство для профилактики и лечения нарушений липоидного и холестеринового обмена веществ
Maronpot et al. Evaluation of 90-day oral rat toxicity studies on the food additive, gum ghatti
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
JP3008138B2 (ja) グアーガム酵素分解物を有効成分とする腸内環境改善剤
Preuss et al. Chitosan as a dietary supplement for weight loss: a review
JP2671353B2 (ja) 点眼剤
Awazu et al. The herbal medicine Sairei-to inhibits proliferation of rat mesangial cells
KR880003628A (ko) 처리된 리피드 조절제
Asvarujanon et al. Inhibitory effects of psyllium on rat mineral absorption were abolished by reduction of viscosity with partial hydrolysis
Spiller Impact of dietary fiber on absorption from the small intestine
JPS6054321A (ja) 粘度の安定なグルコマンナンとビタミンｃの健康食品用製剤
Rosenman et al. Role of cholate in dietary-induced hypercholesteremia of rats and rabbits
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
Elseedy Effect of pomegranate peel and guar gum powders on diabetic rats induced by alloxan

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees